Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 5/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.42 |
| ▸ | PTGIR | P43119 | 10/20 | 0.42 |
| ▸ | DRD3 | P35462 | 3/20 | 0.42 |
| ▸ | DRD4 | P21917 | 2/20 | 0.42 |
| ▸ | PTGDR | Q13258 | 6/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7499160 | 0.92 | PTGIR (0.49) | DRD2NR4A2PTGIRPTGDR | |
| SCHEMBL7485442 | 0.81 | DRD2 (0.50) | DRD2NR4A2DRD3DRD4CA1 | |
| SCHEMBL7492298 | 0.80 | DRD2 (0.46) | DRD2NR4A2DRD3DRD4CA1 | |
| SCHEMBL7494311 | 0.80 | DRD2 (0.43) | DRD2PTGIRDRD3DRD4PTGDR | |
| SCHEMBL7494415 | 0.78 | PTGIR (0.45) | NR4A2PTGIR | |
| SCHEMBL7485190 | 0.77 | NR4A2 (0.50) | DRD2NR4A2PTGIRDRD3PTGDR | |
| SCHEMBL7485549 | 0.75 | PTGIR (0.49) | DRD2NR4A2PTGIRDRD3 | |
| SCHEMBL7483732 | 0.75 | PTGIR (0.51) | DRD2NR4A2PTGIRDRD3 | |
| SCHEMBL7494535 | 0.75 | PTGIR (0.49) | NR4A2PTGIRCA1CA2ACHE | |
| SCHEMBL7488605 | 0.75 | PTGIR (0.49) | NR4A2PTGIRCA1CA2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1213285-A2 | 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-06-12 | — | — | EP | disclosed |
| US-6300344-B1 | FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-09 | — | — | US | disclosed |
| US-5972965-A | USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0842161-A1 | 4,5-DIARYL OXAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-05-20 | — | — | EP | disclosed |
| WO-1997003973-A1 | 4,5-DIARYL OXAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-02-06 | — | — | WO | disclosed |